SFDA CEO States that Saudi Arabia is Utilizing Artificial Intelligence to Create a More Efficient Regulatory Future for Medicines
Amsterdam: CEO of the Saudi Food and Drug Authority (SFDA) Dr. Hisham Aljadhey affirmed that the Kingdom of Saudi Arabia, represented by the SFDA, is effectively integrating artificial intelligence technologies into drug regulatory work, thereby enhancing drug safety and quality. This effort aligns with Saudi Vision 2030, which focuses on